Mon, February 6, 2023
Sun, February 5, 2023
Fri, February 3, 2023
Thu, February 2, 2023

Christopher Raymond Initiated (AGIO) at Buy and Held Target at $41 on, Feb 3rd, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. t-buy-and-held-target-at-41-on-feb-3rd-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Christopher Raymond of Piper Sandler, Initiated "Agios Pharmaceuticals, Inc." (AGIO) at Buy and Held Target at $41 on, Feb 3rd, 2023.

Christopher has made no other calls on AGIO in the last 4 months.



There are 2 other peers that have a rating on AGIO. Out of the 2 peers that are also analyzing AGIO, all agree with Christopher's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Tessa Romero of "JP Morgan" Maintained at Hold with Decreased Target to $33 on, Thursday, December 1st, 2022
  • Salveen Richter of "Goldman Sachs" Upgraded from Strong Sell to Hold and Increased Target to $32 on, Thursday, November 17th, 2022

Publication Contributing Sources